Literature DB >> 9427681

Roles of head and tail domains in alpha-internexin's self-assembly and coassembly with the neurofilament triplet proteins.

G Y Ching1, R K Liem.   

Abstract

The roles of the head and tail domains of alpha-internexin, a type IV neuronal intermediate filament protein, in its self-assembly and coassemblies with neurofilament triplet proteins, were examined by transient transfections with deletion mutants in a non-neuronal cell line lacking an endogenous cytoplasmic intermediate filament network. The results from the self-assembly studies showed that the head domain was essential for alpha-internexin's ability to self-assemble into a filament network and the tail domain was important for establishing a proper filament network. The data from the coassembly studies demonstrated that alpha-internexin interacted differentially with the neurofilament triplet protein subunits. Wild-type NF-L or NF-M, but not NF-H, was able to complement and form a normal filament network with the tailless alpha-internexin mutant, the alpha-internexin head-deletion mutant, or the alpha-internexin mutant missing the entire tail and some amino-terminal portion of the head domain. In contrast, neither the tailless NF-L mutant nor the NF-L head-deletion mutant was able to form a normal filament network with any of these alpha-internexin deletion mutants. However, coassembly of the tailless NF-M mutant with the alpha-internexin head-deletion mutant and coassembly of the NF-M head-deletion mutant with the tailless alpha-internexin mutant resulted in the formation of a normal filament network. Thus, the coassembly between alpha-internexin and NF-M exhibits some unique characteristics previously not observed with other intermediate filament proteins: only one intact tail and one intact head are required for the formation of a normal filament network, and they can be present within the same partner or separately in two partners.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427681     DOI: 10.1242/jcs.111.3.321

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

1.  alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.

Authors:  Nigel J Cairns; Kunihiro Uryu; Eileen H Bigio; Ian R A Mackenzie; Marla Gearing; Charles Duyckaerts; Hideaki Yokoo; Yoichi Nakazato; Evelyn Jaros; Robert H Perry; Steven E Arnold; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2004-05-28       Impact factor: 17.088

2.  Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).

Authors:  R A Armstrong; E Kerty; K Skullerud; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

3.  Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.

Authors:  D Schult; A Hölsken; M Buchfelder; S-M Schlaffer; S Siegel; I Kreitschmann-Andermahr; R Fahlbusch; R Buslei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

4.  Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice.

Authors:  G Y Ching; C L Chien; R Flores; R K Liem
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

5.  Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hideaki Yokoo; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2011-07-27       Impact factor: 3.575

6.  Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.

Authors:  Adijat A Adebola; Theo Di Castri; Chui-Zhen He; Laura A Salvatierra; Jian Zhao; Kristy Brown; Chyuan-Sheng Lin; Howard J Worman; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

7.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.

Authors:  N J Cairns; M Grossman; S E Arnold; D J Burn; E Jaros; R H Perry; C Duyckaerts; B Stankoff; B Pillon; K Skullerud; F F Cruz-Sanchez; E H Bigio; I R A Mackenzie; M Gearing; J L Juncos; J D Glass; H Yokoo; Y Nakazato; S Mosaheb; J R Thorpe; K Uryu; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

8.  The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hedeaki Yokoo; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2010-10-01       Impact factor: 17.088

9.  Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.

Authors:  R A Armstrong; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

10.  RE1 silencing transcription factor is involved in regulating neuron-specific expression of alpha-internexin and neurofilament genes.

Authors:  Gee Y Ching; Ronald K H Liem
Journal:  J Neurochem       Date:  2009-03-23       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.